Cost effective testing Time effective solution Technologically feasible in the developing world, requiring only a fluorescent microscope Straightforward protocol that doesn’t require highly trained technicians Objective microscopy that doesn’t require highly trained pathologists Contact UsAddress797 San Antonio Road Palo Alto, CA 94303Phone1-650.543.2641Fax1-650.213.8042E-mailinfo@idfishtechnology.com

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Theravectys is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Fraunhofer USA, Inc. is a non-profit, research and development organization, which provides applied research services. It conducts applied R&D to customers from industry and state and federal governments. The firm develops and validates scientific applications and technologies for industrial innovation in the USA. The company was founded in 1994 and is headquartered in Plymouth, MI.

Engages in priniting activities

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

GenVec, Inc. (NASDAQ: GNVC) GenVec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec’s development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD).

The Instituto Gulbenkian de Ciência (IGC) is an international centre for biological and biomedical research and graduate training based in Oeiras, Portugal. Founded by the Calouste Gulbenkian Foundation (FCG) in 1961, and still supported by the Foundation, the IGC is organised in small independent research groups that work in an environment designed to encourage interactions with minimal hierarchical structure.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Wuhan Senling Medical Technology Co., Ltd., established on 2019-07-03, Business scope includes medical technology,Biological Technology,Network technology development,technical consulting,Technical Services,technology transfer;Computer Technology Consulting;Technology development of computer hardware and software,Sales;Sales of Class I Medical Devices;Goods and technology import and export business(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Medical information consultation(Does not include medical services);Medical device information consultation;HR Services;Sales of Class II Medical Devices,to develop,Technical Services,consult;Assembly of multifunctional video surveillance recorder,Sales;Machinery and Equipment Leasing.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Novavax is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Novavax recently initiated the development of NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19, with Phase 1 clinical trial results expected in July 2020. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’s proprietary saponin-based Matrix-M™ adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.